Introns 1 and 22 inversions and factor VIII inhibitors in patients with severe haemophilia A in southern Brazil

Haemophilia

Volumn 15, Issue 1, 2009, Pages 309-313

  Leiria, L B ^a   Roisenberg, I ^a   Salzano, Francisco M ^a   Bandinelli, E ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Antibody formation; Brazilian haemophiliacs; Factor VIII inhibitors; Inversions 1 and 22; Risk factors; Severe haemophilia A

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 ANTIBODY; BLOOD CLOTTING FACTOR 8 CRYOPRECIPITATE;

ADULT; ANTIBODY PRODUCTION; ARTICLE; BRAZIL; CHILD; CHROMOSOME ANALYSIS; CHROMOSOME INVERSION; CONTROLLED STUDY; DISEASE SEVERITY; DNA DETERMINATION; DRUG EFFICACY; HEMOPHILIA A; HUMAN; INTRON; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; CHILD; FACTOR VIII; HEMOPHILIA A; HUMANS; INTRONS; INVERSION, CHROMOSOME; ISOANTIBODIES; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RISK FACTORS; YOUNG ADULT;

EID: 63049107351     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01868.x     Document Type: Article

References (47)

1. Lakich D, Kazazian HH Jr, Antonarakis SE, Gitschier J. Inversions disrupting the factor gene are a common cause of severe haemophilia A. Nature Genet 1993; 5: 236-41.
2. Castaldo G, D'Argenio V, Nardiello P et al. Haemophilia A: Molecular insights. Clin Chem Lab Med 2007; 45: 450-61.
3. Salviato R, Belvini D, Radossi P et al. F8 gene mutation profile and ITT response in a cohort of Italian haemophilia A patients with inhibitors. Haemophilia 2007; 13: 361-72.
4. Antonarakis SE, Rossiter JP, Young M et al. Factor VIII gene inversions in severe haemophilia A: Results of an international consortium study. Blood 1995; 86: 2206-12.
5. Oldenburg J, Pavlova A. Genetic risk factors for inhibitors to factors VIII and IX. Haemophilia 2006; 12(Suppl. 6): 15-22.
6. Roisenberg I, Morton NE. Genetic aspects of hemophilias A and B in Rio Grande do Sul, Brazil. Hum Hered 1971; 21: 97-107.
7. Alexandre COP, Roisenberg I. A genetic and demographic study of hemophilia A in Brazil. Hum Hered 1985; 35: 250-4.
8. Rieger A, Roisenberg I. Prevalence of factor VIII inhibitors in patients with hemophilia A in Brazil. Thromb Haemost 1999; 81: 475-6.
9. Simon D, Roisenberg I. Type 2N von Willebrand disease mutations in Brazilian individuals. Haemophilia 2004; 10: 473-6.
10. Lahiri DK, Nurnberger J. A rapid nonenzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucl Acids Res 1991; 19: 5444.
11. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 1988; 16: 1215.
12. Rossetti LC, Radic CP, Larripa IB, De Brasi CD. Genotyping the haemophilia inversion hotspot by use of inverse PCR. Clin Chem 2005; 51: 1154-58.
13. Bagnall RD, Waseem N, Green PM, Giannelli F. Recurrent inversion breaking intron 1 of the factor VIII gene is a frequent cause of severe haemophilia A. Blood 2002; 99: 168-74.
14. Kasper CK, Aledort LM, Counts RB et al. A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh 1975; 34: 869-72.
15. Kasper CK. Laboratory tests for factor VIII inhibitors, their variation, significance and interpretation. Blood Coagul Fibrin 1995; 2: 7-10.
16. Hill M, Deam S, Gordon B, Dolan G. Mutation analysis in 51 patients with haemophilia A: Report of 10 novel mutations and correlations between genotype and clinical phenotype. Haemophilia 2005; 11: 133-41.
17. Boekhorst J, Verbruggen B, Lavergne JM et al. Thirteen novel mutations in the factor VIII gene in the Nijmegen haemophilia A patient population. Br J Haematol 2005; 131: 109-17.
18. Habart D, Kalabova D, Hrachovinova I, Vorlova Z. Significant prevalence of the intron 1 factor VIII gene inversion among patients with severe hemophilia A in the Czech Republic. J Thromb Haemost 2003; 1: 1323-4.
19. Andrikovics H, Klein I, Bors A et al. Analysis of large structural changes of the factor VIII gene, involving intron 1 and 22, in severe hemophilia A. Haematologica 2003; 88: 778-84.
20. Acquila M, Passino M, Lanza T, Bottini F, Boeri E, Bicocchi MP. Frequency of factor VIII intron 1 inversion in a cohort of severe haemophilia A Italian patients. Haematologica 2003; 88: ELT17.
21. Salviato R, Belvini D, Radossi P, Tagariello G. Factor VIII intron 1 inversion: Lower than expected prevalence in Italian haemophiliac severe patients. Haemophilia 2004; 10: 194-6.
22. Riccardi F, Tagliaferri A, Mannotti C, Pattacini C, Neri TM. Intron factor VIII gene inversion in a population of Italian hemophilia A patients. Blood 2002; 100: 3432.
23. Margaglione M, Castaman G, Morfini M et al. The Italian AICE-genetics hemophilia A database: Results and correlation with clinical phenotype. Haematologica 2008; 93: 722-8.
24. Guillet B, Lambert T, d'Oiron R et al. Detection of 95 novel mutations in coagulation Factor VIII gene F8 responsible for hemophilia A: Results from a single institution. Hum Mut 2006; 27: 676-85.
25. RepesséY, Slaoui M, Ferrandiz D et al. Factor VIII (FVIII) gene mutations in 120 patients with hemophilia A: Detection of 26 novel mutations and correlation with FVIII inhibitor development. J Thromb Haemost 2007; 5: 1469-76.
26. Tizzano EF, Domènech M, Altisent C, Tussel J, Baiget M. Inversions in the factor VIII gene in Spanish hemophilia A patients. Blood 1994; 83: 3826.
27. Tizzano EF, Cornet M, Baiget M. Inversion of intron 1 of the factor VIII gene for direct molecular diagnosis of haemophilia A. Haematologica 2003; 88: 118-20.
28. David D, Ventura C, Moreira I et al. The spectrum of mutations and molecular pathogenesis of hemophilia A in 181 Portuguese patients. Haematologica 2006; 91: 840-3.
29. Castaman G, Giacomelli SH, Ghiotto R et al. Spectrum of mutations in Albanian patients with haemophilia A: Identification of ten novel mutations in the factor VIII gene. Haemophilia 2007; 13: 311-6.
30. Rastegar Lari G, Enayat MS, Arjang Z, Lavergne JM, Ala F. Identification of intron 1 and 22 inversion mutations in factor VIII gene of 124 Iranian families with severe haemophilia A. Haemophilia 2004; 10: 410-1.
31. Ahmed R, Kannan M, Choudhry VP, Saxena R. Mutation reports: Intron 1 and 22 inversions in Indian haemophiliacs. Ann Hematol 2003; 82: 546-7.
32. Jayandharan G, Shaji RV, Baidya S, Nair SC, Chandy M, Srivastava A. Identification of factor VIII gene mutations in 101 patients with haemophilia A: Mutation analysis by inversion screening and multiplex PCR and CSGE and molecular modelling of 10 novel missence substitutions. Haemophilia 2005; 11: 481-91.
33. Mantilla-Capacho JM, Beltrán-Miranda CP, Luna-Záizar H et al. Frequency of intron 1 and 22 inversions of factor VIII gene in Mexican patients with severe hemophilia A. Am J Hematol 2007; 82: 283-7.
34. Figueiredo MS, Tavella MH, Simões BP. Large DNA inversions, deletions, and Taq I site mutations in severe haemophilia A. Hum Genet 1994; 94: 473-8.
35. Soares RPS, Chamone DAF, Bydlowski SP. Factor VIII gene inversions and polymorphisms in Brazilian patients with haemophilia A: Carrier detection and prenatal diagnosis. Haemophilia 2001; 7: 299-305.
36. Rossetti LC, Radic CP, Candela M et al. Sixteen novel hemophilia A causative mutations in the first Argentinian series of severe molecular defects. Haematologica 2007; 92: 842-5.
37. Laurie AD, Sheen CR, Hanrahan V, Smith MP, George PM. The molecular aetiology of haemophilia A in a New Zealand patient group. Haemophilia 2007; 13: 420-7.
38. Fernández-López O, García-Lozano J-R, Núñez-Vázquez R, Pérez-Garrido R, Núñez-Roldan A. The spectrum of mutations in southern Spanish patients with hemophilia A and identification of 28 novel mutations. Haematologica 2005; 90: 707-10.
39. Tagariello G, Belvini D, Salviato R et al. Experience of a single Italian center in genetic counseling for hemophilia: From linkage analysis to molecular diagnosis. Haematologica 2000; 85: 525-9.
40. Ghosh K, Shetty S, Kulkarni B et al. Development of inhibitors in patients with haemophilia from India. Haemophilia 2001; 7: 273-8.
41. Reipert BM, van den Helden PMW, Schwarz H-P, Hausl C. Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors. Brit J Haematol 2006; 136: 12-25.
42. Dasgupta S, Navarrete A-M, Delignat S et al. Immune response against therapeutic factor VIII in hemophilia A patients - a survey of probable risk factors. Immunol Lett 2007; 110: 23-8.
43. Gouw SC, van der Bom JG, Auerswald G et al. Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: The CANAL cohort study. Blood 2007; 109: 4693-7.
44. Calvez T, Laurian Y, Goudemand J. Associations between type of product and inhibitors in previously untreated patients (PNPs) with severe hemophilia: Switches and particular products can disturb analysis. Blood 2007; 110: 1073-4.
45. van der Bom JG, Gouw SC, van der Berg HM. Response. Plasma-derived or recombinant factor VIII products and inhibitors in previously untreated patients with severe hemophilia Blood 2007; 110: 1074-5.
46. Delignat S, Dasgupta S, André S et al. Comparison of the immunogenicity of different therapeutic preparations of human factor VIII in the murine model of hemophilia A. Haematologica 2007; 92: 1423-6.
47. Casaña P, Cabrera N, Cid AR et al. Severe and moderate hemophilia A: Identification of 38 new genetic alterations. Haematologica 2008; 93: 1091-4.